• News


Home>NEWS & MEDIA>News

Antipyretic syrup ‘Bearprofen’ released
Day : 2011-05-11

buy low dose naltrexone

buy naltrexone online cheap read here buy low dose naltrexone online

amoxicillin price without insurance

amoxicillin prescription no insurance read here amoxicillin cost without prescription





cheap abortion clinics in georgia

cheap abortion clinics in miami read

cheap abortion in chicago

cheap abortion clinic

prednisolon tabletta

prednisolon click here

citalopram alcohol nhs

citalopram alcohol interaction

abortion clinics in san diego

buy abortion pill

where to buy abortion pill online

can i buy the abortion pill over the counter

strattera discount

strattera coupon

- Rapid effectiveness, and high compliance thanks to strawberry taste

Daewoong Pharmaceutical Co., Ltd (President Lee Jong Wook) has released ‘Bearprofen’ (Ingredient: dexibuprofen), an antipyretic syrup for infantsand children. It has excellent effectiveness in reducing body temperature in cases offever due to cold and acute croup. 

This brand new product uses dexibuprofen, which is effective for flu, while avoiding the R type of Ibuprofen that is not related to remedial effects. For this reason, it shows rapid effects when only a small amount is taken. In particular, as R type has the side effects of hepatotoxicity and gastrointestinal disturbance, dexibuprofen is safer than ibuprofen.
It minimizes the unique taste of dexibuprofen and features a strawberry taste to heighten compliance. Kim Bu Min, Daewoong Pharmaceutical Bearprofen PM, commented "Bearprofen has excellent effectiveness and high compliance. It is up to 53% cheaper than comparable original drugs, and is the cheapest product among competing generics."

The market for infant and children’s antipyretics has a size of about 10 billion won, with an average increase of 3% annually. Bearprofen is expectedto achieve 1.5 billion in sales. 

Prev Obtained patent for high efficiency for Ursa material
Next Daewoong Pharmaceutical Co., Ltd to hold symposium on "Growth factor and skin" at world dermatology conference